Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The Role of Properdin in Zymosan- and Escherichia coli-Induced Complement Activation

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Collagen VI Contains Multiple Host Defense Peptides with Potent In Vivo Activity

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Multiple Homozygous Variants in the STING-Encoding TMEM173 Gene in HIV Long-Term Nonprogressors

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Antibody-Mediated Neutralization of uPA Proteolytic Function Reduces Disease Progression in Mouse Arthritis Models

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Cyclodextrin Reduces Cholesterol Crystal-Induced Inflammation by Modulating Complement Activation

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Fatal pneumococcus meningitis in a child with complement factor ficolin-3 deficiency

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Proteomics-Based Comparative Mapping of the Secretomes of Human Brown and White Adipocytes Reveals EPDR1 as a Novel Batokine

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The impact of mannose-binding lectin polymorphisms on lung function in primary ciliary dyskinesia

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Morten Harboe
  • Peter Garred
  • Julie K Lindstad
  • Anne Pharo
  • Fredrik Müller
  • Gregory L Stahl
  • John D Lambris
  • Tom Erik Mollnes
View graph of relations
Properdin is well known as an enhancer of the alternative complement amplification loop when C3 is activated, whereas its role as a recognition molecule of exogenous pathogen-associated molecular patterns and initiator of complement activation is less understood. We therefore studied the role of properdin in activation of complement in normal human serum by zymosan and various Escherichia coli strains. In ELISA, microtiter plates coated with zymosan induced efficient complement activation with deposition of C4b and terminal complement complex on the solid phase. Virtually no deposition of C4b or terminal complement complex was observed with mannose-binding lectin (MBL)-deficient serum. Reconstitution with purified MBL showed distinct activation in both readouts. In ELISA, normal human serum-induced deposition of properdin by zymosan was abolished by the C3-inhibiting peptide compstatin. Flow cytometry was used to further explore whether properdin acts as an initial recognition molecule reacting directly with zymosan and three E. coli strains. Experiments reported by other authors were made with EGTA Mg(2+) buffer, permitting autoactivation of C3. We found inhibition by compstatin on these substrates, indicating that properdin deposition depended on initial C3b deposition followed by properdin in a second step. Properdin released from human polymorphonuclear cells stimulated with PMA did not bind to zymosan or E. coli, but when incubated in properdin-depleted serum this form of properdin bound efficiently to both substrates in a strictly C3-dependent manner, as the binding was abolished by compstatin. Collectively, these data indicate that properdin in serum as well as polymorphonuclear-released properdin is unable to bind and initiate direct alternative pathway activation on these substrates.
Original languageEnglish
JournalJournal of Immunology
Volume189
Issue number5
Pages (from-to)2606-13
Number of pages8
ISSN0022-1767
DOIs
Publication statusPublished - 2012

ID: 36331314